Search Results - Mechkov, Grigor M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Prospective randomized open‐label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid‐refractory ulcerative colitis

    Prospective randomized open‐label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid‐refractory ulcerative colitis by Baumgart, Daniel C., Targan, Stephan R., Dignass, Axel U., Mayer, Lloyd, Assche, Gert van, Hommes, Daan W., Hanauer, Stephen B., Mahadevan, Uma, Reinisch, Walter, Plevy, Scott E., Salzberg, Bruce A., Buchman, Alan L., Mechkov, Grigor M., Krastev, Zahariy A., Lowder, James N., Frankel, Matthew B., Sandborn, William J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B

    Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B by SENG GEE LIM, KRASTEV, Zahary, TAY MENG NG, MECHKOV, Grigor, KOTZEV, Iskren Andreev, CHAN, Sing, MONDOU, Elsa, SNOW, Andrea, SORBEL, Jeff, ROUSSEAU, Franck

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: